In the core biopsies, high calpastatin expression was significantly associated with adverse breast cancer-specific survival (P=0.035) in the non-inflammatory breast cancer cases (Figure 2C), whereas low calpastatin was significantly associated with adverse survival (P=0.020) in the inflammatory breast cancer cases (Figure 2A). This evidence concerns the gene CAST and inflammatory breast carcinoma.